Drugs / EPODURE
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00542568 | Aug 2008 → Jul 2012 | anemia | Medgenics Medical Israel Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | EPODURE | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00542568 ↗ |
| Route | Subcutaneous | “The EPODURE Biopump is subsequently implanted subcutaneously back to the patient” NCT00542568 ↗ |